Clinical Trials Directory

Trials / Unknown

UnknownNCT03228407

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
McGuire Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

Conditions

Interventions

TypeNameDescription
PROCEDUREConfocal endomicroscopyConfocal laser endomicroscopy (CLE) permits real-time in-vivo histologic analysis of esophageal mucosa at the time of upper endoscopy. The technology is based on the principle of illuminating a tissue with a low-power laser and then detecting fluorescent light reflected from the tissue. Because CLE relies upon tissue fluorescence, intravenous fluorescein is generally used to highlight the vasculature and intercellular spaces of the tissue being examined.
DIAGNOSTIC_TESTEndoscopic biopsiesAdditional biopsies will be obtained of the esophageal mucosa.These will be obtained with a standard biopsy forceps inserted through the channel in gastroscope.
DIAGNOSTIC_TESTMucosal impedance (MI)MI balloon measures epithelial impedance along a 10 cm length of esophagus. The gastroscope will be withdrawn and the MI balloon will be advanced into the esophagus through the mouth. The balloon will be inflated so that the sensors contact the esophageal mucosa. After MI measurements are obtained, the balloon will be deflated and withdrawn.

Timeline

Start date
2017-04-28
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2017-07-24
Last updated
2018-01-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03228407. Inclusion in this directory is not an endorsement.